We’re proud to announce our new service partnership with Catalyst MedTech, a nationally respected leader in imaging service and support. This collaboration helps us expand and strengthen our U.S. service infrastructure—across both Imaginalis and Epica Human Health—to cut downtime, improve responsiveness, and deliver the high-touch support our customers rely on.

The FDA has granted 510(k) clearance for expanded use of the SeeFactor CT3™, enhancing its diagnostic imaging capabilities.

Epica International, a leader in cutting-edge mobile medical imaging systems and precision manufacturing robotics, unveiled their new...

2020 has been a year that none of us will ever forget. While the challenges continue to be numerous and extraordinary, 2020 has also been...

San Clemente, California. Epica International Inc. (Epica), received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...

Epica International, Inc. Announcement San Clemente, California, USA Epica International Inc., a privately held CT Imaging and Robotics...